01 1Aurobindo Pharma Limited
01 1ARIPIPRAZOLE USP (PROCESS II)
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-05-14
Pay. Date : 2019-04-30
DMF Number : 33827
Submission : 2019-04-30
Status : Active
Type : II
20
Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ARIPIPRAZOLE USP (PROCESS II), with a corresponding US DMF Number 33827.
Remarkably, this DMF maintains an Active status since its submission on April 30, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 14, 2019, and payment made on April 30, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
